Obsidian Therapeutics
Biotechnology Research • 
Cambridge, Massachusetts, United States • 51-100 Employees
Company overview
| Headquarters | 1030 Massachusetts Avenue, Suite 400, Cambridge, MA 02138, US |
| Phone number | +17818066245 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Founded | 2015 |
| Employees | 51-100 |
| Socials |
Key Contacts at Obsidian Therapeutics
Todd Hawley
Director Regulatory Affairs Cmc
Madan Jagasia
Chief Executive Officer
Christopher Meyer
Director Program Management
Meisam Bakhshayeshi
Senior Director, Process Development
Arman Aksoy
Director
Gilles Lefebvre
Scientific Director
Emily Chuinard
Director, People Operations
Eric Gennell
Director, Quality Assurance, Obsidian Therapeutics
Rachel Burga
Associate Director
Amanda Kelly
Senior Director, Scientific And Strategic Communications
Obsidian Therapeutics Email Formats
Obsidian Therapeutics uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@obsidiantx.com), used 86% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@obsidiantx.com | 86% |
{last name}{last name} | doedoe@obsidiantx.com | 10% |
{first name}{last name} | johndoe@obsidiantx.com | 2% |
{last name} | doe@obsidiantx.com | 2% |
About Obsidian Therapeutics
Obsidian Therapeutics is pioneering controllable cell and gene therapies to deliver transformative outcomes for patients with intractable diseases. Obsidian’s programs apply our cytoDriveTM technology in cell and gene therapy products to control expression of proteins for enhanced therapeutic efficacy, including our lead program cytoTIL15 engineered to make TILs more effective for more patients. Our aspirations are high, and we’re built to deliver – well-funded with blue chip investors, engaged field-leading advisors, strong partnerships with industry leaders, and a highly experienced, dynamic, innovative and collaborative team, collectively focused on delivering transformative therapies in areas of greatest clinical need. Located in the heart of Cambridge with a new laboratory facility in Bedford, we’re proud of our diverse talented team and committed to cultivating an environment of inclusion where we strive to instill a strong sense of belonging, and support each Obsidianite to continuously learn and contribute their best work. We offer competitive salary and benefits, and potential for employee ownership through stock options.
Obsidian Therapeutics revenue & valuation
| Annual revenue | $4,300,000 |
| Revenue per employee | $50,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $13,800,000 |
| Total funding | $275,500,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Obsidian Therapeutics has 40 employees across 10 departments.
Departments
Number of employees
Funding Data
Explore Obsidian Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Obsidian Therapeutics Tech Stack
Discover the technologies and tools that power Obsidian Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Miscellaneous
Maps
JavaScript libraries
Font scripts
SEO
JavaScript libraries
Webmail
Programming languages
Blogs
Analytics
Germany
United Kingdom
Saudi Arabia
Belgium
Frequently asked questions
4.8
40,000 users
